Senti Biosciences Holdings, Inc. filed a Form 8-K on November 20, 2026, disclosing that it dismissed KPMG LLP as its independent registered public accounting firm effective November 17, 2026, and engaged KNAV CPA LLP as its successor auditor for the fiscal year ending December 31, 2026.
Key Highlights
- Auditor dismissed: KPMG LLP was dismissed as the company's independent registered public accounting firm, effective November 17, 2026, as approved by the Audit Committee.
- New auditor engaged: KNAV CPA LLP was approved by the Audit Committee on November 20, 2026, to serve as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Going concern language: KPMG's audit reports for fiscal years ended December 31, 2025 and 2024 each contained an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern due to recurring losses, negative cash flows from operations, and accumulated deficit.
- Prior material weakness: A material weakness in internal control over financial reporting existed as of December 31, 2024, related to insufficient resources in the finance and accounting function affecting process level control activities over non-routine, unusual, or complex transactions; management concluded it was remediated during the year ended December 31, 2025.
- No disagreements reported: The filing states there were no "disagreements" between the company and KPMG on accounting principles or practices, financial statement disclosure, or auditing scope or procedure during the fiscal years ended December 31, 2025 and 2024, and through November 17, 2026.
- Holding company reorganization: The company underwent a holding company reorganization effective April 24, 2026, making Senti Biosciences Holdings, Inc. the successor issuer to Senti Biosciences, Inc. pursuant to Rule 12g-3(a).
Senti Biosciences Discloses Auditor Change and Prior Internal Control Finding
According to the Form 8-K filed with the SEC on November 20, 2026, Senti Biosciences Holdings, Inc. (NASDAQ:SNTI) notified KPMG LLP on November 17, 2026 that it was terminating KPMG's engagement. The company disclosed that the decision was approved by the Audit Committee of the Board of Directors. The filing notes that KPMG had also served as auditor for Former Senti, the predecessor entity, prior to the holding company reorganization that became effective April 24, 2026.
The filing states that KPMG's audit reports on the company's consolidated financial statements for fiscal years ended December 31, 2025 and December 31, 2024 "did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles," except for going concern explanatory paragraphs in each year. The company also disclosed a previously reported material weakness as of December 31, 2024, which the filing describes as "a lack of sufficient and adequate resources in the finance and accounting function that resulted in ineffective process level control activities over non-routine, unusual, or complex transactions." Management concluded that the material weakness was remediated during the year ended December 31, 2025, according to the filing.
Regarding the incoming firm, the filing states that the Audit Committee approved the engagement of KNAV CPA LLP on November 20, 2026, for the fiscal year ending December 31, 2026. The company disclosed that neither it nor anyone acting on its behalf consulted with KNAV on accounting principles, audit opinion type, or any matter that was the subject of a disagreement or reportable event prior to the engagement. The company authorized KPMG to respond fully to KNAV's inquiries concerning the material weakness, and a letter from KPMG addressed to the SEC is included as Exhibit 16.1 to the filing. The 8-K was signed by Timothy Lu, M.D., Ph.D., Chief Executive Officer.
What Was Disclosed
Senti Biosciences Holdings, Inc. reported the dismissal of KPMG LLP and the engagement of KNAV CPA LLP as its new auditor. The filing also disclosed a previously identified material weakness remediated in 2025 and going concern language in prior audit reports.




Please wait processing your request...